Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4312 results

Sort By:

Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity

Study ID: NCT07021937
Start Date: 2026-05-01
End Date: 2031-04-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

120

Intervention / Treatment

Semaglutide 1.7mg subcutaneous

Placebo

Sponsor

University of Colorado, Denver

Source: clinicaltrials.gov

Share:
Add to list

Early Mindfulness Based Cognitive Therapy for Prevention of Psychological Distress in Cancer Patients

Study ID: NCT07124481
Start Date: 2025-10
End Date: 2027-10
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

208

Intervention / Treatment

Mindfulness based stress reduction

Sponsor

Isala

Source: clinicaltrials.gov

Share:
Add to list

3D Custom Plate vs. Standard Titanium Plates for Mandibular Sub-condylar Fractures Fixation

Study ID: NCT06978530
Start Date: 2025-10-01
End Date: 2026-07-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

3D custom plate

Standard titanium fixation plates

Sponsor

Israa Moussad Tawfiq

Source: clinicaltrials.gov

Share:
Add to list

A Clinical Trial to Investigate Efficacy, Safety and Pharmacokinetics (PK) of Two LXE408 Oral Regimens and Oral Miltefosine as Active Control in Participants Aged ≥ 18 Years Old With Localized Cutaneous Leishmaniasis in the Region of the Americas (AMR).

Study ID: NCT06997159
Start Date: 2025-11-16
End Date: 2027-07-10
Study Type

Interventional

Study Phase

Phase2

No. of Participants

250

Intervention / Treatment

LXE408

Miltefosine 50 mg oral capsules [fearless]

Placebo to LXE408

Sponsor

Drugs for Neglected Diseases

Source: clinicaltrials.gov

Share:
Add to list

Safety and Performance of the Novalung Ultimate Kit and Xenios 2.0 During Stationary Use in Hospital and Ground-based Transport of Patients on Extracorporeal Life Support (ECLS)

Study ID: NCT07156669
Start Date: 2025-10
End Date: 2027-04
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Novalung ultimate kit, Xenios 2.0, and MultiSupport Ground (MSG)

Sponsor

Xenios ag

Source: clinicaltrials.gov

Share:
Add to list

Implementation of a Minimal Equipment Exercise Intervention in Community-dwelling Older Adults With Dementia

Study ID: NCT07119502
Start Date: 2025-10
End Date: 2026-03
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Minimal-equipment progressive resistance training

Sponsor

Geriatric Education and Research Institute

Source: clinicaltrials.gov

Share:
Add to list

The Clinical Research of Traditional Chinese Medicine Compound Formulas

Study ID: NCT07153731
Start Date: 2025-10-01
End Date: 2027-07-01
Study Type

Interventional

Study Phase

Phase4

No. of Participants

100

Intervention / Treatment

S is very healthy

Sponsor

The Fourth Affiliated Hospital of Zhejiang University School of Medicine

Source: clinicaltrials.gov

Share:
Add to list

ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer

Study ID: NCT06922539
Start Date: 2025-10-15
End Date: 2028-10-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

44

Intervention / Treatment

Fenretinide

Fenretinide

Sponsor

SciTech Development, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Bridging Technique Validation for Nasolabial Folds JN-BRIDGE-1

Study ID: NCT07178119
Start Date: 2025-09-30
End Date: 2026-11
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

(Bridging) Horizontal Cannula Technique for Treatment of Nasolabial Folds using AILEENE Vol. 2

Sponsor

Dr. Joseph M Novoa Libermann

Source: clinicaltrials.gov

Share:
Add to list

Leading Healthy Eating and Activity Promotion Program

Study ID: NCT06868524
Start Date: 2025-10-01
End Date: 2029-03-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment
Sponsor

University of Alabama at Birmingham

Source: clinicaltrials.gov

Share:
Add to list